Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 11, 2022 09:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2021 Results

LEXINGTON, Mass., Jan. 11, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced preliminary unaudited financial...
January 11, 2022 09:03 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces the Initiation of the T2Biothreat® Panel Clinical Trial

LEXINGTON, Mass., Jan. 11, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the initation of a U.S. clinical...
January 11, 2022 09:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces the Initiation of the T2Resistance® Panel Clinical Trial

LEXINGTON, Mass., Jan. 11, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the initiation of a U.S....
December 01, 2021 09:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems T2SARS-CoV-2™ Panel Detects Omicron Variant

LEXINGTON, Mass., Dec. 01, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that its T2SARS-CoV-2™ Panel...
November 19, 2021 09:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Continued International Expansion into Taiwan with Exclusive Distribution Agreement

LEXINGTON, Mass., Nov. 19, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the execution of a territory...
November 15, 2021 08:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum

LEXINGTON, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced plans to participate in the...
November 08, 2021 08:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Participates in the World Anti-Microbial Resistance Congress

LEXINGTON, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced it will participate in the 7th annual...
November 04, 2021 16:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Third Quarter 2021 Financial Results

LEXINGTON, Mass., Nov. 04, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced financial results for the three...
November 04, 2021 16:04 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Hires Industry Veteran Brett Giffin as Chief Commercial Officer

LEXINGTON, Mass., Nov. 04, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the appointment of Brett Giffin as...
October 22, 2021 08:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Report Third Quarter 2021 Financial Results on November 4, 2021

LEXINGTON, Mass., Oct. 22, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial...